EZH2 knockout by CRISPR-Cas9 induced MITF in pigmented melanoma cell lines (28:B4:F3 and C006-M1), but not in non-pigmented SK-MEL-28 and A375 cells (Fig. S2B). Here, MITF is linked to melanoma.